Cargando…
Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
BACKGROUND: Chromatin adjoining the site of integration of a transgene affects expression and renders comparisons of closely related transgenes, such as those derived from a BAC deletion series retrofitted with enhancer-traps, unreliable. Gene targeting to a pre-determined site on the chromosome is...
Autores principales: | Chatterjee, Pradeep K, Shakes, Leighcraft A, Stennett, Naima, Richardson, Vanessa L, Malcolm, Tennison L, Harewood, Ken R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841073/ https://www.ncbi.nlm.nih.gov/pubmed/20170521 http://dx.doi.org/10.1186/1756-0500-3-38 |
Ejemplares similares
-
Generating libraries of iTol2-end insertions at BAC ends using loxP and lox511 Tn10 transposons
por: Shakes, Leighcraft A, et al.
Publicado: (2011) -
Minimal cross-recombination between wild-type and loxP511 sites in vivo facilitates truncating both ends of large DNA inserts in pBACe3.6 and related vectors
por: Shakes, Leighcraft A., et al.
Publicado: (2005) -
Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022) -
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015) -
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice
por: Deken, Marcel A., et al.
Publicado: (2016)